AKASA launches autonomous AI for inpatient coding — the mid-cycle "holy grail" touching 1 in 10 US hospital discharges
AKASA launched an autonomous AI platform for the hospital revenue cycle's mid-cycle today, expanding from AI-assisted prebill review into full autonomy for inpatient medical coding and clinical documentation. Its health-system customers already represent about one in ten US inpatient discharges — and the inpatient volume running through its AI products grew nearly sixfold in the past year.
The South San Francisco company, which describes itself as a leader in generative AI for the healthcare revenue cycle, is moving its product from AI-powered prebill review — the end-of-process check before a claim goes out — into autonomy for the two most complex pieces of the middle of the workflow: inpatient medical coding and clinical documentation integrity (CDI).
Why the mid-cycle is the hard part#
The mid-cycle is where a patient's clinical record gets translated into the codes that drive reimbursement, quality reporting, risk adjustment, and the integrity of the patient record. It is highly complex, resource-intensive, and still predominantly manual work done by trained coders and documentation specialists. That is also why it is the most contested territory for healthcare AI: every miscoded chart is either money left on the table or money the hospital has to give back.
The numbers behind the launch#
AKASA says the launch comes amid rapid expansion across its health-system customer base: inpatient volume processed by its AI products has grown almost 6x in the last year. Today, its customers represent more than $180 billion in aggregate net patient revenue and roughly 10% of the country's inpatient discharges — about one in ten. For a company going autonomous in production workflows, that scale is both the proof point and the risk surface.
Fine-tuned per health system#
Rather than one generic coding model, AKASA says it fine-tunes AI models for individual health systems, accounting for differences in patient populations, clinical criteria, documentation practices, and care complexity. The pitch: complete documentation and accurate coding that better reflect the care actually delivered, adapted to how each hospital already works rather than forcing the hospital to adapt to the model.
Holy-grail talk#
CEO and co-founder Malinka Walaliyadde cast the launch as an industry milestone: "For years, an autonomous mid-cycle has been a holy grail in our industry," he said. "Today, AKASA is making it real." He framed the timing around healthcare's demand crunch: "The incredible demand for healthcare is finally being addressed by advancements in AI. Multiple parts of the healthcare ecosystem will need to scale up, with documentation and coding being critical components."
The claim that matters most is the one about autonomy, not assistance. Prebill review lets humans stay in the loop; autonomous mid-cycle moves the loop itself. If the 6x volume growth is real, it suggests health systems are already voting with their discharge data — and the question now is whether autonomous coding holds up at 1-in-10-discharges scale.